BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24935219)

  • 1. Embryological signaling pathways in Barrett's metaplasia development and malignant transformation; mechanisms and therapeutic opportunities.
    Pavlov K; Meijer C; van den Berg A; Peters FT; Kruyt FA; Kleibeuker JH
    Crit Rev Oncol Hematol; 2014 Oct; 92(1):25-37. PubMed ID: 24935219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical outline of Barrett's esophagus].
    Kuwano H; Sohda M; Kato H; Miyazaki T; Kimura H
    Nihon Rinsho; 2005 Aug; 63(8):1372-8. PubMed ID: 16101224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carcinogenesis of Barrett's esophagus].
    Endo T; Sugawara N; Shinomura Y
    Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The esophagitis to adenocarcinoma sequence; the role of inflammation.
    Kavanagh ME; O'Sullivan KE; O'Hanlon C; O'Sullivan JN; Lysaght J; Reynolds JV
    Cancer Lett; 2014 Apr; 345(2):182-9. PubMed ID: 23994342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in columnar lined esophagus (Barrett's metaplasia)?
    Tadiparthi R; Bansal A; Sharma P
    Curr Opin Gastroenterol; 2008 Jul; 24(4):516-20. PubMed ID: 18622169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma.
    Meyer C; Hejazi R; Bansal A
    Curr Opin Gastroenterol; 2021 Jul; 37(4):378-383. PubMed ID: 33883421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in Barrett's esophagus and esophageal adenocarcinoma.
    Dinjens WN
    Minerva Chir; 2002 Dec; 57(6):733-52. PubMed ID: 12592217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of Barrett's cancer.
    Atherfold PA; Jankowski JA
    Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Barrett's esophagus free of dysplasia.
    DeMeester SR
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
    Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
    Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
    Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digestive disease week 2011: highlights of clinical and preclinical research on Barrett's esophagus and associated esophageal adenocarcinoma.
    van de Winkel A; Massl R; Kuipers EJ; van der Laan LJ; Peppelenbosch MP
    Dis Esophagus; 2013; 26(2):130-40. PubMed ID: 22458661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances in the pathogenesis and progression of barrett's esophagus.
    Streppel MM; Montgomery EA; Maitra A
    Curr Mol Med; 2014 Jan; 14(1):58-68. PubMed ID: 23865431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural alterations of the mucosa stroma in the Barrett's esophagus metaplasia-dysplasia-adenocarcinoma sequence.
    Bobryshev YV; Killingsworth MC; Lord RV
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1498-504. PubMed ID: 22591183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
    Morgan G
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques.
    May A; Gossner L; Pech O; Müller H; Vieth M; Stolte M; Ell C
    Endoscopy; 2002 Aug; 34(8):604-10. PubMed ID: 12173079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.